Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups

Background. New oral anticoagulants (NOAC; rivaroxaban, dabigatran, apixaban) have become available as an alternative to warfarin anticoagulation in non-valvular atrial fibrillation (NVAF). Methods. MEDLINE and CENTRAL, regulatory agencies websites, clinical trials registers and conference proceedin...

Descripción completa

Detalles Bibliográficos
Autores principales: Gómez-Outes, Antonio, Terleira-Fernández, Ana Isabel, Calvo-Rojas, Gonzalo, Suárez-Gea, M. Luisa, Vargas-Castrillón, Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3885278/
https://www.ncbi.nlm.nih.gov/pubmed/24455237
http://dx.doi.org/10.1155/2013/640723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3885278/
https://www.ncbi.nlm.nih.gov/pubmed/24455237
http://dx.doi.org/10.1155/2013/640723

Ejemplares similares